The Enterprise Value as of December 2025 (TTM) for Arcturus Therapeutics Holdings Inc. (ARCT) is 26.78M

According to Arcturus Therapeutics Holdings Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 26.78M. This represents a change of -87.89% compared to the average of 221.12M of the last 4 quarters.

Arcturus Therapeutics Holdings Inc. (ARCT) Historical Enterprise Value (quarterly & annually)

How has ARCT Enterprise Value performed in the past?

The mean historical Enterprise Value of Arcturus Therapeutics Holdings Inc. over the last ten years is 236.34M. The current 26.78M Enterprise Value has changed 1.03% with respect to the historical average. Over the past ten years (40 quarters), ARCT's Enterprise Value was at its highest in in the September 2021 quarter at 911.79M. The Enterprise Value was at its lowest in in the December 2018 quarter at 18.93M.

Arcturus Therapeutics Holdings Inc. (ARCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arcturus Therapeutics Holdings Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arcturus Therapeutics Holdings Inc. (ARCT) Average Enterprise Value

How has ARCT Enterprise Value performed in the past?

The current Enterprise Value of Arcturus Therapeutics Holdings Inc. (ARCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Arcturus Therapeutics Holdings Inc. (ARCT) Enterprise Value vs. Peers

How is ARCT’s Enterprise Value compared to its peers?

Arcturus Therapeutics Holdings Inc.’s Enterprise Value is less than Sagimet Biosciences Inc. (164.48M), less than Humacyte, Inc. (196.00M), less than Voyager Therapeutics, Inc. (235.09M), less than Entrada Therapeutics, Inc. (347.42M), less than Vanda Pharmaceuticals Inc. (243.49M), less than Achieve Life Sciences, Inc. (232.44M), less than Foghorn Therapeutics Inc. (208.87M), less than Immuneering Corporation (220.51M), less than Zura Bio Limited (113.92M), less than Atea Pharmaceuticals, Inc. (154.94M),

Build a custom stock screener for Arcturus Therapeutics Holdings Inc. (ARCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcturus Therapeutics Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arcturus Therapeutics Holdings Inc. (ARCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arcturus Therapeutics Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.